View in EDS

Mapping drug-drug interactions in pharmacokinetic boosting of olaparib.

Saved in:
Bibliographic Details
Title: Mapping drug-drug interactions in pharmacokinetic boosting of olaparib.
Authors: Overbeek JK; Department of Pharmacy, Pharmacology and Toxicology, Radboud university medical center, PO box 9101, Nijmegen, 6500HB, the Netherlands. j.k.overbeek@lumc.nl., Naoom SMS; Department of Pharmacy, Pharmacology and Toxicology, Radboud university medical center, PO box 9101, Nijmegen, 6500HB, the Netherlands., Nijboer L; Department of Pharmacy, Pharmacology and Toxicology, Radboud university medical center, PO box 9101, Nijmegen, 6500HB, the Netherlands., Bloemendal HJ; Department of Medical Oncology, Radboud university medical center, Nijmegen, Netherlands., Ottevanger PB; Department of Medical Oncology, Radboud university medical center, Nijmegen, Netherlands., van Erp NP; Department of Pharmacy, Pharmacology and Toxicology, Radboud university medical center, PO box 9101, Nijmegen, 6500HB, the Netherlands., Burger DM; Department of Pharmacy, Pharmacology and Toxicology, Radboud university medical center, PO box 9101, Nijmegen, 6500HB, the Netherlands., Ter Heine R; Department of Pharmacy, Pharmacology and Toxicology, Radboud university medical center, PO box 9101, Nijmegen, 6500HB, the Netherlands.
Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2026 Jan 19; Vol. 96 (1), pp. 9. Date of Electronic Publication: 2026 Jan 19.
Publication Type: Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1432-0843
DOI:10.1007/s00280-025-04858-6